longbridge

MICOT PHARMA-B

02335

About

MICOT PHARMA-B
MICOT PHARMA-B
02335.HK

Shaanxi Micot Pharmaceutical Technology Co., Ltd. engages in discovery, development and commercialization of bi-/multi-specific peptide drugs. The company engages in discovery, development and commercialization of bi-/multi-specific peptide drugs for the treatment of metabolic diseases as well as for cancer, cardiovascular, cerebrovascular, and neurological systemic diseases. The company was founded in founded in 2007 and is headquartered in Xi'an, China.

Profile

Company Name
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Market
SEHK
Founded
Industry
Pharmaceuticals
Fiscal Year End
--

Industry

55 stocks in this industry
1134
Industry RankingsValue(HKD)Rank
Market Value13.09B17/55
Revenue TTM0.0055/55
Profits TTM-199.79M47/55
ROE(TTM)42.41%4/55
Dividend Yield0.00%55/55

Management

© 2026 LongbridgeTerms of ServicePrivacy Policy